ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL CANCER INSTITUTE

Mechanisms of Replication Stress Tolerance in SCLC

Active
Institution
NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY
Principal investigator
Tony Tung Huang
Funding
$352K
Duration
2024–2029
Open portfolio

Moonbase score

Still being scored

Abstract

PROJECT 2 SUMMARY Exacerbating replication stress is a powerful means to kill cancer cells through mitotic catastrophe due to intolerable levels of DNA replication-associated lesions and DNA breaks. Replication stress is a hallmark of SCLC due to several intrinsic factors, including the loss of tumor suppressors p53 and RB1 in nearly 100% of SCLC. As a consequence of replication stress, constitutive activation of the replication stress response (RSR) pathway(s) is a critical measure to counterbalance cancer cell survival and genomic instability in SCLC. In dealing with high levels of endogenous and/or exogenous replication stress, we hypothesize that SCLC cells have acquired an intricate genome-wide protective mechanism to counteract high levels of replication stress. However, the molecular details and signaling pathways that mediate replication stress tolerance in SCLC cells remains ill-defined, especially in conditions leading to relapsed SCLC. In Project 2, we will address this knowledge gap with the following specific Aims: in Aim 1, we will characterize the RSR pathway(s) that enable replication stress tolerance in SCLC cells. In Aim 2, we will determine how RSR pathways regulate chemo-resistance in SCLC models. Defining the unique therapeutic vulnerabilities of these SCLC subtypes and how they can overcome chemotherapy resistance should help to focus and accelerate therapeutics research, leading to rationally- targeted approaches that may ultimately improve clinical outcomes for patients with this disease. The research work will be highly coordinated within the Program Project with the other three Projects and the three Cores. Our combined diverse approaches include molecular biology, functional genomics, and cell biology. We will employ mutants of different RSR proteins and initiate experiments based on results shared with projects 1, 3, and 4, which will be constantly monitored with feedback via Core A. SCLC cell lines and PDX models will be supported by Core B, and advanced imaging platform and computational analysis will be supported by Core C.

LOADING MOONBASE SCORE

NATIONAL CANCER INSTITUTEP01ZCA1-RPRB-Mreplicationstresstolerancereplication stressdna breakssclctumor suppressorshigh levels

Questions for NEW YORK UNIVERSITY SCHOOL OF MEDICINE

Answered by the team behind this research.

Same researchers, same institution, same topic, scored first.